At this dose, a 10 mg vial lasts 2.5 weeks
Patients diagnosed with diabetes are initiating GLP-1 treatment more quickly than ever before Since 2021, the average time between a diabetes diagnosis and the initiation of a GLP-1 therapy has decreased by about one month, underscoring how quickly these drugs have moved to the forefront of care
For patients, this means tirzepatide may affect overall blood pressure patterns, not just one isolated number
Neuromuscul Disord 30(6):492502 Giovarelli M, Zecchini S, Casati SR, Lociuro L, Gjana O, Mollica L et al (2025) The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery
Cons: Major surgery, long-term nutritional requirements, higher initial risk
24/7 Access: Connect with doctors anytime across all 50 states